Thomas J.  Farley net worth and biography

Thomas Farley Biography and Net Worth

Insider of Aditxt
From December 2015 to June 2020, Mr. Farley was the Controller and Treasurer of Business Development Corporation of America (“BDCA”), a publicly listed business development company. Prior thereto, from January 2011 to August 2015, Mr. Farley was the Senior Controller of Blackrock Capital Investment Corporation (NASDAQ: BKCC). Prior to joining BlackRock Capital Investment Corporation, Mr. Farley was a Senior Controller for PineBridge Investments Emerging Markets practice. Mr. Farley was also an Accounting Manager for Bessemer Venture Partners prior to his tenue at PineBridge. Mr. Farley began his career with PricewaterhouseCoopers LLP, from 1996 to 2001. Mr. Farley earned his B.S. in Accounting from Long Island University and is a Certified Public Accountant

What is Thomas J. Farley's net worth?

The estimated net worth of Thomas J. Farley is at least $161.20 as of May 26th, 2021. Mr. Farley owns 62 shares of Aditxt stock worth more than $161 as of April 25th. This net worth estimate does not reflect any other assets that Mr. Farley may own. Additionally, Mr. Farley receives an annual salary of $357,890.00 as Insider at Aditxt. Learn More about Thomas J. Farley's net worth.

How old is Thomas J. Farley?

Mr. Farley is currently 51 years old. There are 4 older executives and no younger executives at Aditxt. The oldest executive at Aditxt is Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D., Co-Founder, Chief Innovation Officer, Secretary & Director, who is 61 years old. Learn More on Thomas J. Farley's age.

What is Thomas J. Farley's salary?

As the Insider of Aditxt, Inc., Mr. Farley earns $357,890.00 per year. There are 2 executives that earn more than Mr. Farley. The highest earning executive at Aditxt is Mr. Amro A. Albanna, Co-Founder, Chairman & CEO, who commands a salary of $472,120.00 per year. Learn More on Thomas J. Farley's salary.

How do I contact Thomas J. Farley?

The corporate mailing address for Mr. Farley and other Aditxt executives is 2569 WYANDOTTE ST. SUITE 101, MOUNTAIN CA, 94043. Aditxt can also be reached via phone at 650-870-1200 and via email at [email protected]. Learn More on Thomas J. Farley's contact information.

Has Thomas J. Farley been buying or selling shares of Aditxt?

Thomas J. Farley has not been actively trading shares of Aditxt over the course of the past ninety days. Most recently, on Wednesday, May 26th, Thomas J. Farley bought 62 shares of Aditxt stock. The stock was acquired at an average cost of $107.20 per share, with a total value of $6,646.40. Following the completion of the transaction, the insider now directly owns 62 shares of the company's stock, valued at $6,646.40. Learn More on Thomas J. Farley's trading history.

Who are Aditxt's active insiders?

Aditxt's insider roster includes Thomas Farley (Insider), Corinne Pankovcin (CFO), and Shahrokh Shabahang (Insider). Learn More on Aditxt's active insiders.

Are insiders buying or selling shares of Aditxt?

During the last twelve months, insiders at the sold shares 1 times. They sold a total of 20,800 shares worth more than $691,184.00. The most recent insider tranaction occured on September, 7th when Major Shareholder Paribas Securities Corp Bnp sold 20,800 shares worth more than $691,184.00. Insiders at Aditxt own 1.2% of the company. Learn More about insider trades at Aditxt.

Information on this page was last updated on 9/7/2023.

Thomas J. Farley Insider Trading History at Aditxt

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/26/2021Buy62$107.20$6,646.4062View SEC Filing Icon  
See Full Table

Thomas J. Farley Buying and Selling Activity at Aditxt

This chart shows Thomas J Farley's buying and selling at Aditxt by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aditxt Company Overview

Aditxt logo
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. It is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Read More

Today's Range

Now: $2.60
Low: $2.27
High: $2.69

50 Day Range

MA: $3.25
Low: $2.22
High: $4.00

2 Week Range

Now: $2.60
Low: $2.14
High: $68.08

Volume

140,681 shs

Average Volume

343,103 shs

Market Capitalization

$624,000.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29